Sitagliptin Sandoz 25 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin sandoz 25 mg

sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg

Sitagliptin Sandoz 50 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin sandoz 50 mg

sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg

Sitagliptin Sandoz 100 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin sandoz 100 mg

sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg

Januvia 50 mg 挪威 - 挪威文 - Statens legemiddelverk

januvia 50 mg

orifarm as - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 50 mg

Sitagliptin/Metformin Krka 50 mg / 1000 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin/metformin krka 50 mg / 1000 mg

krka, d.d. novo mesto - sitagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg

Sitagliptin/Metformin Krka 50 mg / 850 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin/metformin krka 50 mg / 850 mg

krka, d.d. novo mesto - sitagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg

Sitagliptin Krka 25 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin krka 25 mg

krka, d.d. novo mesto - sitagliptin - tablett, filmdrasjert - 25 mg

Sitagliptin Krka 50 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin krka 50 mg

krka, d.d. novo mesto - sitagliptin - tablett, filmdrasjert - 50 mg

Sitagliptin Krka 100 mg 挪威 - 挪威文 - Statens legemiddelverk

sitagliptin krka 100 mg

krka, d.d. novo mesto - sitagliptin - tablett, filmdrasjert - 100 mg

Sitagliptin / Metformin hydrochloride Sun 欧盟 - 挪威文 - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.